Open Label Study of Omacetaxine Mepesuccinate in Patients With Advanced CML
- Study Title
- Open Label Study of Subcutaneous Homoharringtonine (Omacetaxine Mepesuccinate) in Patients With Advanced CML
- Teva Identifier
- CGX-635-CML-203 | 2007-001286-15
- ClinicalTrials.gov Identifier
- NCT00462943
- Study Status
- Completed
- Trial Condition(s)
- Chronic Myeloid Leukemia
- Interventions
- Drug: Omacetaxine mepesuccinate
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years and older
- Trial Duration
- 03/01/2007 - 09/01/2013
- Phase
- Phase 2
